We encourage you to read the full editorial and comment at Kentucky.com.
By Boyd Haley At issue | June 26 Chicago Tribune article, "FDA warns Lexington maker of autism pill"
This is just one of several Chicago Tribune articles focusing on criticism of doctors who treat autistic children, raising similar concerns to that of a fringe group called Neurodiversity, which thinks autism should be celebrated instead of treated.
It is critical to be noted that there has been no report of any significant adverse effect for OSR#1. Our legal representation has contacted the Food and Drug Administration and we are working with the agency to resolve its concerns...
Read more: Kentucky.com